Denali Therapeutics Inc. Common Stock

DNLI us
$20.39
▼ 0.08 (-0.39%)
Volume: 1,257,469 · 2026-09-25

📈 Price Chart

Loading…
RSI (14)

🧭 Style Verdicts

🚀 Momentum 20
  • 21d momentum -17.0%
  • MA aligned bearish
  • RSI 38
🎯 Pullback 50
  • -5.2% vs 20MA
💎 Value 58
  • -25% off 52w high

Scores (0–100) derived from live technical & fundamental metrics. Not investment advice.

📐 Technicals

RSI(14)37.5
MACD-0.006
MA trendBearish
ATR4.28%
21d mom.-17.0%
63d mom.-20.3%
vs 20MA-5.2%
RVOL(20)0.78×
52w low · 14 52w high · 27
-25.3% from 52-week high
20d support 19 · resistance 25

Computed live from daily OHLCV · as of 2026-09-25

🏦 Fundamentals

Market cap$3.3B
PER—
PBR3.92
PSR907.90
EPS$-3.21
ROE-61.4%
ROA-44.3%
Dividend yield0.00%
Debt/Equity0.01
EV/EBITDA-5.80
week1M3M6M1YYTD
+3.40% -17.01% -20.26% +3.32% +51.26% +25.32%

Valuation and profitability in USD, latest reported 2026-09-24. Period returns are price-based.

⚖️ AI Bull vs Bear

🐂 Bull
3/10
🐻 Bear
8/10

14d momentum -8.48%, daily vol 2.46%. Denali Therapeutics Inc. Common Stock sits in a bearish regime.

Derived from 14-day momentum and daily volatility on real OHLCV.

🗞 Related News

No recent news.